Categories
Change Password!
Reset Password!
To assess the safety and efficacy of transcutaneous electrical nerve stimulation (TENS) treatment for alleviating pain among females with primary dysmenorrhea (PD).
Primary dysmenorrhea (PD) is characterised by cramping pain in the
lower abdomen that occurs just before or during menstruation in women. This
pain can be relieved by NSAIDS or oral cantraceptives. Unfortunately, these
agents are often associated with adverse events. In this research, Hai-Yan Ba et
al introduce new transcutaneous electrical nerve stimulation (TENS) therapy
to provide pain relief for patients with PD.
To assess the safety and efficacy of transcutaneous
electrical nerve stimulation (TENS) treatment for alleviating pain among
females with primary dysmenorrhea (PD).
A total of 134 participants with PD were selected anjd
categorised into sham and intervention group. Patients of sham received sham
TENS and intervention group obtained TENS. Numeric Rating Scale (NRS) was used
to measure the primary endpoint and the number of ibuprofen tablets taken, the World
Health Organization quality of life (WHOQOL)-BREF score, adverse events, and
the duration of relief from dysmenorrheal pain was taken as the secondary
endpoints.
One hundred twenty-two patients accomplished the
analysis. TENS showed a more substantial
impact in pain relief about the NRS (P < .01), the number of Ibuprofen
tablets taken, and duration of relief from dysmenorrheal pain as compared to
the sham TENS. Although, no notable differences in the quality of life was
noticed between the groups. The adverse effects profiles were also alike within
the groups.
TENS was effective and safe in alleviating pain among the
patients with PD.
Medicine. 96(36):e7959, SEP 2017
Effect of transcutaneous electrical nerve stimulation therapy for the treatment of primary dysmenorrhea
Hai-Yan Bai et al.
Comments (0)